Overview

Evaluation of Patiromer in Heart Failure Patients

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.

Phase:

Phase 2

Details

Lead Sponsor:

Relypsa, Inc.

Collaborator:

Medpace, Inc.